Which has grown faster, BRKR or PTGX?

Over the past five years, PTGX grew revenue faster — BRKR at a 9.10% CAGR versus PTGX at 59.63%.

Does BRKR or PTGX pay a bigger dividend?

BRKR pays a dividend (0.23% yield), while PTGX has no payments in the available dividend history.

Is BRKR or PTGX more profitable?

PTGX runs the higher net margin — BRKR at -2.03% versus PTGX at 29.40%.

How have BRKR and PTGX total returns compared?

Over the past 10 years, BRKR delivered 11.49% and PTGX delivered 20.54% annualized total return. Past performance doesn't predict future results.

Bruker Corporation (BRKR) vs Protagonist Therapeutics, Inc. (PTGX)

A side-by-side comparison of Bruker Corporation and Protagonist Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BRKR

Bruker Corporation

$9.24B

$60.67HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT

PTGX

Protagonist Therapeutics, Inc.

$8.88B

$138.14HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT

Total return — BRKR vs PTGX

growth of $100 · dividends reinvested · last 10y

BRKR +196.6% (+11.5%/yr)PTGX +563.0% (+20.8%/yr)PTGX compounded faster over this window

BRKR PTGX

BRKR vs PTGX: by the numbers

•BRKR is the larger company ($9.24B vs $8.88B market cap).
•PTGX is profitable (29.40% net margin) while BRKR runs a net loss (-2.03%).
•PTGX grew revenue faster over the past five years (59.63% vs 9.10% CAGR).
•BRKR pays a dividend (0.23% yield), while PTGX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BRKR	PTGX
P/E ratio	N/A	133.64
Forward P/E	28.59	N/A
P/S ratio	2.64	31.50
P/B ratio	3.85	10.56
EV / EBITDA	30.75	141.49
FCF yield	1.02%	1.47%

Profitability

Metric	BRKR	PTGX
Gross margin	46.69%	99.86%
Operating margin	3.61%	-343.63%
Net margin	-2.03%	29.40%
ROE	-2.97%	9.85%
ROIC	2.56%	6.74%

Dividends

Metric	BRKR	PTGX
Dividend yield	0.23%	N/A

Growth (annualized)

Metric	BRKR	PTGX
Revenue CAGR (5Y)	9.10%	59.63%
FCF CAGR (5Y)	-21.33%	N/A
Total return CAGR (5Y)	-3.42%	50.88%

Frequently asked

Which has grown faster, BRKR or PTGX?: Over the past five years, PTGX grew revenue faster — BRKR at a 9.10% CAGR versus PTGX at 59.63%.
Does BRKR or PTGX pay a bigger dividend?: BRKR pays a dividend (0.23% yield), while PTGX has no payments in the available dividend history.
Is BRKR or PTGX more profitable?: PTGX runs the higher net margin — BRKR at -2.03% versus PTGX at 29.40%.
How have BRKR and PTGX total returns compared?: Over the past 10 years, BRKR delivered 11.49% and PTGX delivered 20.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BRKR analysis Full PTGX analysis Interactive comparison tool

Dig into the metrics

Protagonist Therapeutics P/E ratio Bruker dividend yield Bruker ROE Protagonist Therapeutics ROE Bruker operating margin Protagonist Therapeutics operating margin Bruker revenue growth Protagonist Therapeutics revenue growth Bruker free cash flow Protagonist Therapeutics free cash flow

Bruker & Protagonist Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.